The status of zinc in the development of hepatocellular cancer

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10 - 29; http://dx.doi.org/10.3322/caac.20138; PMID: 22237781
   PubMed Web of Science ®Google Scholar
• Teoh NC. Proliferative drive and liver carcinogenesis: too much of a good thing?. J Gastroenterol Hepatol 2009; 24:1817 - 25; http://dx.doi.org/10.1111/j.1440-1746.2009.06121.x; PMID: 20002941
   PubMed Web of Science ®Google Scholar
• Danielsen A, Steinnes E. A study of some selected trace elements in normal and cancerous tissue by neutron activation analysis. J Nucl Med 1970; 11:260 - 4; PMID: 4316187
   PubMed Web of Science ®Google Scholar
• Tashiro H, Kawamoto T, Okubo T, Koide O. Variation in the distribution of trace elements in hepatoma. Biol Trace Elem Res 2003; 95:49 - 63; http://dx.doi.org/10.1385/BTER:95:1:49; PMID: 14555799
   PubMed Web of Science ®Google Scholar
• Ebara M, Fukuda H, Hatano R, Saisho H, Nagato Y, Suzuki K, Nakajima K, Yukawa M, Kondo F, Nakayama A, et al. Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. J Hepatol 2000; 33:415 - 22; http://dx.doi.org/10.1016/S0168-8278(00)80277-9; PMID: 11019997
   PubMed Web of Science ®Google Scholar
• Kawata T, Nakamura S, Nakayama A, Fukuda H, Ebara M, Nagamine T, Minami T, Sakurai H. An improved diagnostic method for chronic hepatic disorder: analyses of metallothionein isoforms and trace metals in the liver of patients with hepatocellular carcinoma as determined by capillary zone electrophoresis and inductively coupled plasma-mass spectrometry. Biol Pharm Bull 2006; 29:403 - 9; http://dx.doi.org/10.1248/bpb.29.403; PMID: 16508136
   PubMed Web of Science ®Google Scholar
• Kew MC, Mallett RC. Hepatic zinc concentrations in primary cancer of the liver. Br J Cancer 1974; 29:80 - 3; http://dx.doi.org/10.1038/bjc.1974.11; PMID: 4820950
   PubMed Web of Science ®Google Scholar
• Liaw KY, Lee PH, Wu FC, Tsai JS, Lin-Shiau SY. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am J Gastroenterol 1997; 92:2260 - 3; PMID: 9399766
   PubMed Web of Science ®Google Scholar
• Tashiro-Itoh T, Ichida T, Matsuda Y, Satoh T, Sugiyama M, Tanaka Y, Ishikawa T, Itoh S, Nomoto M, Asakura H. Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma. Liver 1997; 17:300 - 6; http://dx.doi.org/10.1111/j.1600-0676.1997.tb01036.x; PMID: 9455736
   PubMedGoogle Scholar
• Al-Ebraheem A, Farquharson MJ, Ryan E. The evaluation of biologically important trace metals in liver, kidney and breast tissue. Appl Radiat Isot 2009; 67:470 - 4; http://dx.doi.org/10.1016/j.apradiso.2008.06.018; PMID: 18675548
   PubMed Web of Science ®Google Scholar
• Wright EB, Dormandy TL. Liver zinc in carcinoma. Nature 1972; 237:166; http://dx.doi.org/10.1038/237166a0; PMID: 4555509
   PubMed Web of Science ®Google Scholar
• Maeda T, Shimada M, Harimoto N, Tsujita E, Maehara S, Rikimaru T, Tanaka S, Shirabe K, Maehara Y. Role of tissue trace elements in liver cancers and non-cancerous liver parenchyma. Hepatogastroenterology 2005; 52:187 - 90; PMID: 15783026
   PubMed Web of Science ®Google Scholar
• Ebara M, Fukuda H, Kojima Y, Morimoto N, Yoshikawa M, Sugiura N, Satoh T, Kondo F, Yukawa M, Matsumoto T, et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 1999; 210:81 - 8; http://dx.doi.org/10.1148/radiology.210.1.r99ja4181; PMID: 9885591
   PubMed Web of Science ®Google Scholar
• Franklin RB, Levy BA, Zou J, Hanna N, Desouki MM, Bagasra O, Johnson LA, Costello LC. ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer. J Gastrointest Cancer 2012; 43:249 - 57; http://dx.doi.org/10.1007/s12029-011-9269-x; PMID: 21373779
   PubMedGoogle Scholar
• Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 2007; 463:211 - 7; http://dx.doi.org/10.1016/j.abb.2007.02.033; PMID: 17400177
   PubMed Web of Science ®Google Scholar
• Franklin RB, Costello LC. The important role of the apoptotic effects of zinc in the development of cancers. J Cell Biochem 2009; 106:750 - 7; http://dx.doi.org/10.1002/jcb.22049; PMID: 19160419
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB. Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity. Expert Rev Anticancer Ther 2012; 12:121 - 8; http://dx.doi.org/10.1586/era.11.190; PMID: 22149438
   PubMed Web of Science ®Google Scholar
• Jayaraman AK, Jayaraman S. Increased level of exogenous zinc induces cytotoxicity and up-regulates the expression of the ZnT-1 zinc transporter gene in pancreatic cancer cells. J Nutr Biochem 2011; 22:79 - 88; http://dx.doi.org/10.1016/j.jnutbio.2009.12.001; PMID: 20392624
   PubMed Web of Science ®Google Scholar
• Sliwinski T, Czechowska A, Kolodziejczak M, Jajte J, Wisniewska-Jarosinska M, Blasiak J. Zinc salts differentially modulate DNA damage in normal and cancer cells. Cell Biol Int 2009; 33:542 - 7; http://dx.doi.org/10.1016/j.cellbi.2009.02.004; PMID: 19254773
   PubMed Web of Science ®Google Scholar
• Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999; 40:200 - 7; http://dx.doi.org/10.1002/(SICI)1097-0045(19990801)40:3<200::AID-PROS8>3.0.CO;2-3; PMID: 10398282
   PubMed Web of Science ®Google Scholar
• Feng P, Li TL, Guan ZX, Franklin RB, Costello LC. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 2002; 52:311 - 8; http://dx.doi.org/10.1002/pros.10128; PMID: 12210492
   PubMed Web of Science ®Google Scholar
• Feng P, Li T, Guan Z, Franklin RB, Costello LC. The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. Mol Cancer 2008; 7:25; http://dx.doi.org/10.1186/1476-4598-7-25; PMID: 18331646
   PubMed Web of Science ®Google Scholar
• Costello LC, Fenselau CC, Franklin RB. Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells. J Inorg Biochem 2011; 105:589 - 99; http://dx.doi.org/10.1016/j.jinorgbio.2011.02.002; PMID: 21440525
   PubMed Web of Science ®Google Scholar
• Taylor KM, Morgan HE, Johnson A, Nicholson RI. Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14. FEBS Lett 2005; 579:427 - 32; http://dx.doi.org/10.1016/j.febslet.2004.12.006; PMID: 15642354
   PubMed Web of Science ®Google Scholar
• Lichten LA, Cousins RJ. Interleukin-1beta contributes via nitric oxide to the upregulation and functional activity of the zinc transporter Zip14 (Slc39a14) in murine hepatocytes. Annu Rev Nutr 2009; 29:153 - 76; http://dx.doi.org/10.1146/annurev-nutr-033009-083312; PMID: 19400752
   PubMed Web of Science ®Google Scholar
• Liuzzi JP, Lichten LA, Rivera S, Blanchard RK, Aydemir TB, Knutson MD, Ganz T, Cousins RJ. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A 2005; 102:6843 - 8; http://dx.doi.org/10.1073/pnas.0502257102; PMID: 15863613
   PubMed Web of Science ®Google Scholar
• Cousins RJ, Liuzzi JP, Lichten LA. Mammalian zinc transport, trafficking, and signals. J Biol Chem 2006; 281:24085 - 9; http://dx.doi.org/10.1074/jbc.R600011200; PMID: 16793761
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhu X, Zhu J, Liao S, Tang Q, Liu K, Guan X, Zhang J, Feng Z. Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray. Oncol Rep 2007; 18:943 - 51; PMID: 17786358
   PubMed Web of Science ®Google Scholar
• Shen R, Xie F, Shen H, liu Q, Zheng T, Kou X, Wang D, Yang J. Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells. PLoS One 2013; 8:e56542; http://dx.doi.org/10.1371/journal.pone.0056542; PMID: 23437163
   PubMedGoogle Scholar
• Weaver BP, Zhang Y, Hiscox S, Guo GL, Apte U, Taylor KM, Sheline CT, Wang L, Andrews GK. Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration. PLoS One 2010; 5:e13158; http://dx.doi.org/10.1371/journal.pone.0013158; PMID: 20957146
   PubMedGoogle Scholar
• Urani C, Melchioretto P, Gribaldo L. Regulation of metallothioneins and ZnT-1 transporter expression in human hepatoma cells HepG2 exposed to zinc and cadmium. Toxicol In Vitro 2010; 24:370 - 4; http://dx.doi.org/10.1016/j.tiv.2009.11.003; PMID: 19900532
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB. The genetic/metabolic transformation concept of carcinogenesis. Cancer Metastasis Rev 2012; 31:123 - 30; http://dx.doi.org/10.1007/s10555-011-9334-8; PMID: 22109079
   PubMed Web of Science ®Google Scholar
• Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer 2005; 4:32; http://dx.doi.org/10.1186/1476-4598-4-32; PMID: 16153295
   PubMed Web of Science ®Google Scholar
• Johnson LA, Kanak MA, Kajdacsy-Balla A, Pestaner JP, Bagasra O. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods 2010; 52:316 - 21; http://dx.doi.org/10.1016/j.ymeth.2010.08.004; PMID: 20705137
   PubMed Web of Science ®Google Scholar
• Costello LC, Zou J, Desouki MM, Franklin RB. Evidence for changes in RREB-1, ZIP3, and Zinc in the early development of pancreatic adenocarcinoma. J Gastrointest Cancer 2012; 43:570 - 8; http://dx.doi.org/10.1007/s12029-012-9378-1; PMID: 22427155
   PubMedGoogle Scholar
• Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973; 26:217 - 23; http://dx.doi.org/10.1136/jcp.26.3.217; PMID: 4700503
   PubMed Web of Science ®Google Scholar
• Koo JS, Kim H, Park BK, Ahn SH, Han KH, Chon CY, Park C, Park YN. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B. J Clin Gastroenterol 2008; 42:738 - 43; http://dx.doi.org/10.1097/MCG.0b013e318038159d; PMID: 18277883
   PubMed Web of Science ®Google Scholar
• Le Bail B, Bernard PH, Carles J, Balabaud C, Bioulac-Sage P. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol 1997; 27:835 - 42; http://dx.doi.org/10.1016/S0168-8278(97)80321-2; PMID: 9382971
   PubMed Web of Science ®Google Scholar
• Libbrecht L, Craninx M, Nevens F, Desmet V, Roskams T. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 2001; 39:66 - 73; http://dx.doi.org/10.1046/j.1365-2559.2001.01172.x; PMID: 11454046
   PubMed Web of Science ®Google Scholar
• Podda M, Roncalli M, Battezzati PM, Borzio M, Bruno S, Servida E, Coggi G. Liver-cell dysplasia and hepatocellular carcinoma. Ital J Gastroenterol 1992; 24:39 - 42; PMID: 1315175
   PubMedGoogle Scholar
• Kazi TG, Kolachi NF, Afridi HI, Kazi NG, Sirajuddin, Naeemullah, Arain SS. Effects of mineral supplementation on liver cirrhotic/cancer male patients. Biol Trace Elem Res 2012; 150:81 - 90; http://dx.doi.org/10.1007/s12011-012-9501-y; PMID: 22968625
   PubMed Web of Science ®Google Scholar
• Moriyama M, Matsumura H, Fukushima A, Ohkido K, Arakawa Y, Nirei K, Yamagami H, Kaneko M, Tanaka N, Arakawa Y. Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease. Dig Dis Sci 2006; 51:1967 - 77; http://dx.doi.org/10.1007/s10620-005-9051-7; PMID: 17048113
   PubMed Web of Science ®Google Scholar
• Chin-Thin W, Wei-Tun C, Tzu-Ming P, Ren-Tse W. Blood concentrations of selenium, zinc, iron, copper and calcium in patients with hepatocellular carcinoma. Clin Chem Lab Med 2002; 40:1118 - 22; http://dx.doi.org/10.1515/cclm.2002.196; PMID: 12521229
   PubMedGoogle Scholar
• Lin CC, Huang JF, Tsai LY, Huang YL. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res 2006; 109:15 - 24; http://dx.doi.org/10.1385/BTER:109:1:015; PMID: 16388099
   PubMed Web of Science ®Google Scholar
• Pramoolsinsap C, Promvanit N, Komindr S, Lerdverasirikul P, Srianujata S. Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand. J Gastroenterol 1994; 29:610 - 5; http://dx.doi.org/10.1007/BF02365444; PMID: 8000510
   PubMed Web of Science ®Google Scholar
• Reichen J. The role of the sinusoidal endothelium in liver function. News Physiol Sci 1999; 14:117 - 21; PMID: 11390834
   PubMedGoogle Scholar
• Keeling PW, Ruse W, Bull J, Hannigan B, Thompson RP. Direct measurement of the hepatointestinal extraction of zinc in cirrhosis and hepatitis. Clin Sci (Lond) 1981; 61:441 - 4; PMID: 7285494
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 2006; 5:17; http://dx.doi.org/10.1186/1476-4598-5-17; PMID: 16700911
   PubMed Web of Science ®Google Scholar
• Costello LC, Levy BA, Desouki MM, Zou J, Bagasra O, Johnson LA, Hanna N, Franklin RB. Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma. Cancer Biol Ther 2011; 12:297 - 303; http://dx.doi.org/10.4161/cbt.12.4.16356; PMID: 21613827
   PubMed Web of Science ®Google Scholar
• Lemire J, Mailloux R, Appanna VD. Zinc toxicity alters mitochondrial metabolism and leads to decreased ATP production in hepatocytes. J Appl Toxicol 2008; 28:175 - 82; http://dx.doi.org/10.1002/jat.1263; PMID: 17582580
   PubMed Web of Science ®Google Scholar
• Costello LC, Liu Y, Franklin RB, Kennedy MC. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 1997; 272:28875 - 81; http://dx.doi.org/10.1074/jbc.272.46.28875; PMID: 9360955
   PubMed Web of Science ®Google Scholar
• Sharma V, Anderson D, Dhawan A. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis 2012; 17:852 - 70; http://dx.doi.org/10.1007/s10495-012-0705-6; PMID: 22395444
   PubMed Web of Science ®Google Scholar
• Akhtar MJ, Ahamed M, Kumar S, Khan MM, Ahmad J, Alrokayan SA. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine 2012; 7:845 - 57; PMID: 22393286
   PubMed Web of Science ®Google Scholar
• Matsumura H, Nirei K, Nakamura H, Arakawa Y, Higuchi T, Hayashi J, Yamagami H, Matsuoka S, Ogawa M, Nakajima N, et al. Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C. J Clin Biochem Nutr 2012; 51:178 - 84; PMID: 23170044
   PubMed Web of Science ®Google Scholar